Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 15

1.

Correction: Genetically enhanced T lymphocytes and the intensive care unit.

Tat T, Li H, Constantinescu CS, Onaciu A, Chira S, Osan C, Pasca S, Petrushev B, Moisoiu V, Micu WT, Berce C, Tranca S, Dima D, Berindan-Neagoe I, Shen J, Tomuleasa C, Qian L.

Oncotarget. 2018 Aug 10;9(62):32097. doi: 10.18632/oncotarget.25983. eCollection 2018 Aug 10.

2.

Genetically enhanced T lymphocytes and the intensive care unit.

Tat T, Li H, Constantinescu CS, Onaciu A, Chira S, Osan C, Pasca S, Petrushev B, Moisoiu V, Micu WT, Berce C, Tranca S, Dima D, Berindan-Neagoe I, Shen J, Tomuleasa C, Qian L.

Oncotarget. 2018 Mar 27;9(23):16557-16572. doi: 10.18632/oncotarget.24637. eCollection 2018 Mar 27. Review. Erratum in: Oncotarget. 2018 Aug 10;9(62):32097.

3.

Protein dysregulation in graft versus host disease.

Qian L, Dima D, Berce C, Liu Y, Rus I, Raduly LZ, Liu Y, Petrushev B, Berindan-Neagoe I, Irimie A, Tanase A, Jurj A, Shen J, Tomuleasa C.

Oncotarget. 2017 Dec 15;9(1):1483-1491. doi: 10.18632/oncotarget.23276. eCollection 2018 Jan 2. Review.

4.

Advances in the treatment of newly diagnosed primary central nervous system lymphomas.

Qian L, Tomuleasa C, Florian IA, Shen J, Florian IS, Zdrenghea M, Dima D.

Blood Res. 2017 Sep;52(3):159-166. doi: 10.5045/br.2017.52.3.159. Epub 2017 Sep 25. Review.

5.

Therapeutic effects of hydrogen on chronic graft-versus-host disease.

Qian L, Liu X, Shen J, Zhao D, Yin W.

J Cell Mol Med. 2017 Oct;21(10):2627-2630. doi: 10.1111/jcmm.13155. Epub 2017 Apr 4.

6.

Treatment of newly diagnosed B-cell origin primary CNS lymphoma with systemic R-IDARAM chemotherapy and intrathecal immunochemotherapy.

Qian L, Zhou C, Shen J, Cen J, Yin W.

Oncotarget. 2016 May 3;7(18):25783-90. doi: 10.18632/oncotarget.8370.

7.

The novel anti-CD19 chimeric antigen receptors with humanized scFv (single-chain variable fragment) trigger leukemia cell killing.

Qian L, Li D, Ma L, He T, Qi F, Shen J, Lu XA.

Cell Immunol. 2016 Jun-Jul;304-305:49-54. doi: 10.1016/j.cellimm.2016.03.003. Epub 2016 Mar 14.

PMID:
26996927
8.

Myelodysplastic syndrome with neutrophilic panniculitis: A report of two cases and a literature review.

Qian L, Shen J, Cen J, Yin W, Ma Y.

Oncol Lett. 2015 Apr;9(4):1954-1956. Epub 2015 Feb 4.

9.

Administration of hydrogen-rich saline in mice with allogeneic hematopoietic stem-cell transplantation.

Yuan L, Chen X, Qian L, Shen J, Cai J.

Med Sci Monit. 2015 Mar 12;21:749-54. doi: 10.12659/MSM.891338.

10.

Acute myelocytic leukemia in a patient with hemophagocytic lymphohistiocytosis: A case report.

Zhao D, Qian L, Shen J.

Oncol Lett. 2014 Dec;8(6):2634-2636. Epub 2014 Sep 12.

11.

Successful treatment of hemorrhagic cystitis after HLA-mismatched allogeneic hematopoietic stem cell transplantation by hyperbaric oxygen.

Qian L, Shen J, Zhao D, Pan S.

Transplantation. 2014 Apr 15;97(7):e41-2. doi: 10.1097/TP.0000000000000049. No abstract available.

PMID:
24686429
12.

Combined treatment of rituximab, idarubicin, dexamethasone, cytarabine, methotrexate with radiotherapy for primary central nervous system lymphoma.

Zhao D, Qian L, Shen J, Liu X, Mei K, Cen J, Wang Y, Li C, Ma Y.

J Cell Mol Med. 2014 Jun;18(6):1081-6. doi: 10.1111/jcmm.12252. Epub 2014 Mar 13.

13.

Primary bone marrow B-cell non-Hodgkin's lymphoma successfully treated with R-CHOP.

Qian L, Zhang Z, Shen J, Liu Y.

West Indian Med J. 2013 Jan;62(1):89-91.

PMID:
24171336
14.

Hydrogen as a new class of radioprotective agent.

Qian L, Shen J, Chuai Y, Cai J.

Int J Biol Sci. 2013 Sep 14;9(9):887-94. doi: 10.7150/ijbs.7220. eCollection 2013. Review.

15.

Advances in the treatment of acute graft-versus-host disease.

Qian L, Wu Z, Shen J.

J Cell Mol Med. 2013 Aug;17(8):966-75. doi: 10.1111/jcmm.12093. Epub 2013 Jun 26. Review.

Supplemental Content

Loading ...
Support Center